Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert I Haddad

Showing results (1-10 of 184) with videos related to

Pageof 19
Sort By:
Journal of the National Cancer Institute|July 2, 2009
Re: Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservationRobert I Haddad
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
How to incorporate new tyrosine kinase inhibitors in the treatment of patients with medullary thyroid cancerRobert I Haddad
Journal of the National Comprehensive Cancer Network : JNCCN|May 25, 2013
New developments in thyroid cancerRobert I Haddad
Targeted Oncology|October 15, 2024
Physician Perspectives on the Management of Patients with Resected High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck Who Are Ineligible to Receive Cisplatin: A PodcastRobert I Haddad, Kevin Harrington
Oral Oncology|July 31, 2012
Overcoming resistance to EGFR inhibitor in head and neck cancer: a review of the literatureGuilherme Rabinowits, Robert I Haddad
Hematology/Oncology Clinics of North America|November 17, 2015
Sequential and Concurrent Chemoradiation: State of the ArtNicole G Chau, Robert I Haddad
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2009
Induction chemotherapy in head and neck cancerRobert I Haddad, Marshall R Posner
The Journal of Supportive Oncology|December 1, 2007
Novel agents for the treatment of mucositisMarshall R Posner, Robert I Haddad
Frontiers in Oncology|September 12, 2019
Best Practice in Systemic Therapy for Head and Neck Squamous Cell CarcinomaSjoukje F Oosting, Robert I Haddad
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 13, 2012
Vandetanib for the treatment of medullary thyroid cancerNicole G Chau, Robert I Haddad
Pageof 19

Showing results (1-10 of 184) with videos related to

Sort By:
Pageof 19
Journal of the National Cancer Institute|July 2, 2009
Re: Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservationRobert I Haddad
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
How to incorporate new tyrosine kinase inhibitors in the treatment of patients with medullary thyroid cancerRobert I Haddad
Journal of the National Comprehensive Cancer Network : JNCCN|May 25, 2013
New developments in thyroid cancerRobert I Haddad
Targeted Oncology|October 15, 2024
Physician Perspectives on the Management of Patients with Resected High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck Who Are Ineligible to Receive Cisplatin: A PodcastRobert I Haddad, Kevin Harrington
Oral Oncology|July 31, 2012
Overcoming resistance to EGFR inhibitor in head and neck cancer: a review of the literatureGuilherme Rabinowits, Robert I Haddad
Hematology/Oncology Clinics of North America|November 17, 2015
Sequential and Concurrent Chemoradiation: State of the ArtNicole G Chau, Robert I Haddad
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2009
Induction chemotherapy in head and neck cancerRobert I Haddad, Marshall R Posner
The Journal of Supportive Oncology|December 1, 2007
Novel agents for the treatment of mucositisMarshall R Posner, Robert I Haddad
Frontiers in Oncology|September 12, 2019
Best Practice in Systemic Therapy for Head and Neck Squamous Cell CarcinomaSjoukje F Oosting, Robert I Haddad
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 13, 2012
Vandetanib for the treatment of medullary thyroid cancerNicole G Chau, Robert I Haddad
Pageof 19